Stocks · NYSE · Healthcare · United States

TEVA — Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (TEVA) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 39.81 (+2.39% on the day), +10.4% over one month, +19.1% over three months, +107.6% over twelve months. The InvestMuse composite score is +12 on a −100 to +100 scale, a mixed read that ranks #483 of about 1,221 assets. The strongest of its nine dimensions are Trend (+74) and Momentum (+54); the weakest is Sector edge (-53). Its volatility regime from the hidden Markov model is Calm. 27 news articles in the last 30 days carried an average tone of +0.31 (on −1 to +1).

Open the interactive read →Race TEVA with $100k play money

The facts

Last close	39.81 (September 29, 2026)
1 day / 1 month / 3 months / 12 months	+2.39% / +10.4% / +19.1% / +107.6%
52-week range	18.95 – 40.22
Composite score	+12 / 100 · mixed view · rank #483
Volatility regime (HMM)	Calm
Support levels	8.50
Resistance levels	56.00
Trailing P/E	56.7
Market cap	$40.0B

The nine dimensions

Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.

Regime (hidden Markov model)-30
Technical indicators-13
Trend+74
Support / resistance0
Fundamentals+29
Sector edge-53
News sentiment+30
Momentum+54
Chart patterns and zones-3

How this read is made

Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.

Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.